Curaleaf Holdings Inc CURLF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
The cannabis rescheduling is causing celebration - and confusion - as marijuana stocks sell off
-
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
-
Canadian Cannabis Stocks Jump on Report U.S. May Move to Reclassify Marijuana
-
Marijuana stocks sell off as Trump signs executive order to reclassify cannabis
-
Pot stocks keep blazing after Trump says he's 'very strongly' looking at rescheduling cannabis
-
Cannabis Stocks Rally After Trump Highlights Cannabidiol for Senior Care
Trading Information
- Previous Close Price
- $10.26
- Day Range
- $9.80–10.40
- 52-Week Range
- $1.80–12.45
- Bid/Ask
- — / —
- Shares Outstanding
- 264.81M
- Market Cap
- $8.15B
- Volume/Avg
- 166,644 / 178,239
Key Statistics
- Price/Earnings (Normalized)
- 154.00
- Price/Sales
- 2.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,519
- Website
- https://www.curaleaf.com
Valuation
|
Metric
|
CURLF
|
|---|---|
Price/Earnings (Normalized) | 154.00 |
Price/Book Value | 3.14 |
Price/Sales | 2.13 |
Price/Cash Flow | 15.28 |
Price/Earnings
CURLF
Financial Strength
|
Metric
|
CURLF
|
|---|---|
Quick Ratio | 0.58 |
Current Ratio | 1.52 |
Interest Coverage | 0.06 |
Quick Ratio
CURLF
Profitability
|
Metric
|
CURLF
|
|---|---|
Return on Assets (Normalized) | 0.16% |
Return on Equity (Normalized) | 0.56% |
Return on Invested Capital (Normalized) | 5.29% |
Return on Assets
CURLF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|MzG#!!& | LOCK|T$Y< | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|tmJ$KmZ | LOCK|gnw<w | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|$%%yJMZ | LOCK|kj | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|%vd!?fnM | LOCK|&> | $29B | |||
| Viatris Inc
VTRS
| LOCK|TvhRm&# | LOCK|?r | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|@% | LOCK|y% | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|c^c^X! | LOCK|Rb | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|&<VHmx | LOCK|%< | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|P?@%CR | LOCK|!>%n | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|p&##y>J | LOCK|&>< | $2B |
United States